Trevi Therapeutics (TRVI) Other Non-Current Liabilities (2018 - 2022)

Trevi Therapeutics' Other Non-Current Liabilities history runs 4 years deep, the most recent figure standing at $3000.0 for Q4 2022.

• In Q4 2022, Other Non-Current Liabilities fell 97.37% year-over-year to $3000.0; the TTM figure through Dec 2022 stood at $3000.0 (down 97.37% YoY), while the FY2022 annual figure was $3000.0, down 97.37% from the prior year.
• Other Non-Current Liabilities for Q4 2022 stood at $3000.0, down from $15000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $1.1 million in Q4 2018, with the low at $3000.0 in Q4 2022.
• The 4-year median for Other Non-Current Liabilities is $125000.0 (2022), against an average of $197636.4.
• Peak annual rise in Other Non-Current Liabilities reached 2.94% in 2022, while the deepest fall reached 97.37% in 2022.
• Trevi Therapeutics' Other Non-Current Liabilities stood at $1.1 million in 2018, then sank by 82.12% to $196000.0 in 2020, then sank by 41.84% to $114000.0 in 2021, then plunged by 97.37% to $3000.0 in 2022.
• Business Quant data shows TRVI's Other Non-Current Liabilities at $3000.0 in Q4 2022, $15000.0 in Q3 2022, and $35000.0 in Q2 2022.